确定治疗疼痛是否有效的标准
1The University of Newcastle, Newcastle, Australia, PO Box 431, East Maitland, NSW, 2323, Australia.
Interventional pain medicine
|September 6, 2024
概括
治疗有效性声明需要具体的结果数据,而不仅仅是一般的结果. 患者需要全面,透明的数据来评估治疗是否满足他们的满意度.
科学领域:
- 临床研究方法论临床研究方法论
- 基于证据的医学是基于证据的医学.
- 患者报告的结果
背景情况:
- 关于治疗疗效的说法往往没有得到充分的支持.
- 缺乏具体的结果量化阻碍了临床决策.
- 当前的报告标准可能无法充分说明治疗的好处.
研究的目的:
- 倡导一个更严格和透明的方法来报告治疗结果.
- 强调需要详细的结果数据来评估治疗的有效性.
- 为了指导读者批判性地评估治疗要求.
主要方法:
- 批评当前对治疗结果的报告实践.
- 强调验证仪器对于测量功能,心理困扰和医疗保健利用的重要性.
- 倡导使用分类数据和延长后续期.
主要成果:
- 平均得分和p值不足以理解治疗影响.
- 分类数据对于量化治疗效应 (多大,多频) 是必不可少的.
- 结果需要监测,直到稳定,以提供一个完整的画面.
结论:
- 治疗要求必须用具体的,全面的结果数据来证明.
- 读者应该要求透明度和详细的结果,以便做出明智的决定.
- 转向更具信息性的结果报告对于基于证据的实践至关重要.
相关概念视频
Analgesia and Pain Management
552
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
552
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K


